These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7569441)

  • 1. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
    Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
    Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Temporal variation of genotypes and serotypes of enterohemorrhagic E Coli isolated from Chilean children with intestinal infections or hemolytic uremic syndrome].
    Prado V; Martínez J; Arellano C; Levine MM
    Rev Med Chil; 1997 Mar; 125(3):291-7. PubMed ID: 9460265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
    Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
    Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
    Allerberger F; Sölder B; Caprioli A; Karch H
    Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
    Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
    Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarrheagenic E. coli in hospitalized patients: special reference to Shiga-like toxin producing Escherichia coli.
    Lanjewar M; De AS; Mathur M
    Indian J Pathol Microbiol; 2010; 53(1):75-8. PubMed ID: 20090227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].
    Karch H; Köhler B
    Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
    Karch H
    Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic uremic syndrome: co-infection with two different serotypes of Shiga-like toxin producing Escherichia coli.
    Rivas M; Voyer L; Tous M; Leardini N; de Mena MF; Wainsztein R; Callejo R; Prado V; Binsztein N
    Medicina (B Aires); 1993; 53(6):487-90. PubMed ID: 8084244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen.
    Mellmann A; Bielaszewska M; Zimmerhackl LB; Prager R; Harmsen D; Tschäpe H; Karch H
    Clin Infect Dis; 2005 Sep; 41(6):785-92. PubMed ID: 16107974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro susceptibility of enterohemorrhagic Escherichia coli to 11 antimicrobials. Relationship between antibiotic resistance and toxigenic genotype].
    Prado V; Basualdo W; Arellano C; Martínez J; Levine MM
    Rev Med Chil; 1995 Sep; 123(9):1085-90. PubMed ID: 8728731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.
    Cordovéz A; Prado V; Maggi L; Cordero J; Martinez J; Misraji A; Rios R; Soza G; Ojeda A; Levine MM
    J Clin Microbiol; 1992 Aug; 30(8):2153-7. PubMed ID: 1500525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.
    Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A
    Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.
    Cornick NA; Jelacic S; Ciol MA; Tarr PI
    J Infect Dis; 2002 Jul; 186(1):57-63. PubMed ID: 12089662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.